Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 541 to 551 of 551 entries
Sorted by: Best Match Show Resources per page
Ultra-sensitive Sb speciation analysis in water samples by magnetic ionic liquid dispersive liquid-liquid microextraction and multivariate optimization.

Analytical methods : advancing methods and applications

Oviedo MN, Fiorentini EF, Lemos AA, Wuilloud RG.
PMID: 33555281
Anal Methods. 2021 Mar 04;13(8):1033-1042. doi: 10.1039/d0ay02276d.

Efficient separation and preconcentration of inorganic Sb species in different water samples were performed in this work by a novel dispersive liquid-liquid microextraction (DLLME) method based on the application of a magnetic ionic liquid (MIL) and electrothermal atomic absorption...

Cite
Oviedo MN, Fiorentini EF, Lemos AA, et al. Ultra-sensitive Sb speciation analysis in water samples by magnetic ionic liquid dispersive liquid-liquid microextraction and multivariate optimization. Anal Methods. 2021;13(8):1033-1042doi: 10.1039/d0ay02276d.
Oviedo, M. N., Fiorentini, E. F., Lemos, A. A., & Wuilloud, R. G. (2021). Ultra-sensitive Sb speciation analysis in water samples by magnetic ionic liquid dispersive liquid-liquid microextraction and multivariate optimization. Analytical methods : advancing methods and applications, 13(8), 1033-1042. https://doi.org/10.1039/d0ay02276d
Oviedo, María N, et al. "Ultra-sensitive Sb speciation analysis in water samples by magnetic ionic liquid dispersive liquid-liquid microextraction and multivariate optimization." Analytical methods : advancing methods and applications vol. 13,8 (2021): 1033-1042. doi: https://doi.org/10.1039/d0ay02276d
Oviedo MN, Fiorentini EF, Lemos AA, Wuilloud RG. Ultra-sensitive Sb speciation analysis in water samples by magnetic ionic liquid dispersive liquid-liquid microextraction and multivariate optimization. Anal Methods. 2021 Mar 04;13(8):1033-1042. doi: 10.1039/d0ay02276d. PMID: 33555281.
Copy Download .nbib Format: NLM
Sex-specific differences and postoperative outcomes of minimally invasive and sternotomy valve surgery.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

Moscarelli M, Lorusso R, Angelini GD, Di Bari N, Paparella D, Fattouch K, Albertini A, Nasso G, Fiorentino F, Speziale G.
PMID: 34392335
Eur J Cardiothorac Surg. 2021 Aug 15; doi: 10.1093/ejcts/ezab369. Epub 2021 Aug 15.

OBJECTIVES: Female sex is an established risk factor for postoperative complications after heart surgery, but the influence of sex on outcomes after minimally invasive cardiac surgery (MICS) for valvular replacement/repair remains controversial. We examined whether the role of sex...

Cite
Moscarelli M, Lorusso R, Angelini GD, et al. Sex-specific differences and postoperative outcomes of minimally invasive and sternotomy valve surgery. Eur J Cardiothorac Surg. 2021;doi: 10.1093/ejcts/ezab369.
Moscarelli, M., Lorusso, R., Angelini, G. D., Di Bari, N., Paparella, D., Fattouch, K., Albertini, A., Nasso, G., Fiorentino, F., & Speziale, G. (2021). Sex-specific differences and postoperative outcomes of minimally invasive and sternotomy valve surgery. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, . https://doi.org/10.1093/ejcts/ezab369
Moscarelli, Marco, et al. "Sex-specific differences and postoperative outcomes of minimally invasive and sternotomy valve surgery." European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery vol. (2021). doi: https://doi.org/10.1093/ejcts/ezab369
Moscarelli M, Lorusso R, Angelini GD, Di Bari N, Paparella D, Fattouch K, Albertini A, Nasso G, Fiorentino F, Speziale G. Sex-specific differences and postoperative outcomes of minimally invasive and sternotomy valve surgery. Eur J Cardiothorac Surg. 2021 Aug 15; doi: 10.1093/ejcts/ezab369. Epub 2021 Aug 15. PMID: 34392335.
Copy Download .nbib Format: NLM
The Use of Augmented Reality to Guide the Intraoperative Frozen Section During Robot-assisted Radical Prostatectomy.

European urology

Bianchi L, Chessa F, Angiolini A, Cercenelli L, Lodi S, Bortolani B, Molinaroli E, Casablanca C, Droghetti M, Gaudiano C, Mottaran A, Porreca A, Golfieri R, Romagnoli D, Giunchi F, Fiorentino M, Piazza P, Puliatti S, Diciotti S, Marcelli E, Mottrie A, Schiavina R.
PMID: 34332759
Eur Urol. 2021 Oct;80(4):480-488. doi: 10.1016/j.eururo.2021.06.020. Epub 2021 Jul 29.

BACKGROUND: Multiparametric magnetic resonance imaging (mpMRI) can guide the surgical plan during robot-assisted radical prostatectomy (RARP), and intraoperative frozen section (IFS) can facilitate real-time surgical margin assessment.OBJECTIVE: To assess a novel technique of IFS targeted to the index lesion...

Cite
Bianchi L, Chessa F, Angiolini A, et al. The Use of Augmented Reality to Guide the Intraoperative Frozen Section During Robot-assisted Radical Prostatectomy. Eur Urol. 2021;80(4):480-488doi: 10.1016/j.eururo.2021.06.020.
Bianchi, L., Chessa, F., Angiolini, A., Cercenelli, L., Lodi, S., Bortolani, B., Molinaroli, E., Casablanca, C., Droghetti, M., Gaudiano, C., Mottaran, A., Porreca, A., Golfieri, R., Romagnoli, D., Giunchi, F., Fiorentino, M., Piazza, P., Puliatti, S., Diciotti, S., Marcelli, E., Mottrie, A., & Schiavina, R. (2021). The Use of Augmented Reality to Guide the Intraoperative Frozen Section During Robot-assisted Radical Prostatectomy. European urology, 80(4), 480-488. https://doi.org/10.1016/j.eururo.2021.06.020
Bianchi, Lorenzo, et al. "The Use of Augmented Reality to Guide the Intraoperative Frozen Section During Robot-assisted Radical Prostatectomy." European urology vol. 80,4 (2021): 480-488. doi: https://doi.org/10.1016/j.eururo.2021.06.020
Bianchi L, Chessa F, Angiolini A, Cercenelli L, Lodi S, Bortolani B, Molinaroli E, Casablanca C, Droghetti M, Gaudiano C, Mottaran A, Porreca A, Golfieri R, Romagnoli D, Giunchi F, Fiorentino M, Piazza P, Puliatti S, Diciotti S, Marcelli E, Mottrie A, Schiavina R. The Use of Augmented Reality to Guide the Intraoperative Frozen Section During Robot-assisted Radical Prostatectomy. Eur Urol. 2021 Oct;80(4):480-488. doi: 10.1016/j.eururo.2021.06.020. Epub 2021 Jul 29. PMID: 34332759.
Copy Download .nbib Format: NLM
Correction to: Discrepancy of p16 immunohistochemical expression and HPV RNA in penile cancer. A multiplex in situ hybridization/immunohistochemistry approach study.

Infectious agents and cancer

Marino FZ, Sabetta R, Pagliuca F, Brunelli M, Aquino G, Perdonà S, Botti G, Facchini G, Fiorentino F, Di Lauro G, De Sio M, De Vita F, Toni G, Reis RBD, Neder L, Franco R.
PMID: 33845840
Infect Agent Cancer. 2021 Apr 12;16(1):23. doi: 10.1186/s13027-021-00363-6.

No abstract available.

Cite
Marino FZ, Sabetta R, Pagliuca F, et al. Correction to: Discrepancy of p16 immunohistochemical expression and HPV RNA in penile cancer. A multiplex in situ hybridization/immunohistochemistry approach study. Infect Agent Cancer. 2021;16(1):23doi: 10.1186/s13027-021-00363-6.
Marino, F. Z., Sabetta, R., Pagliuca, F., Brunelli, M., Aquino, G., Perdonà, S., Botti, G., Facchini, G., Fiorentino, F., Di Lauro, G., De Sio, M., De Vita, F., Toni, G., Reis, R. B. D., Neder, L., & Franco, R. (2021). Correction to: Discrepancy of p16 immunohistochemical expression and HPV RNA in penile cancer. A multiplex in situ hybridization/immunohistochemistry approach study. Infectious agents and cancer, 16(1), 23. https://doi.org/10.1186/s13027-021-00363-6
Marino, Federica Zito, et al. "Correction to: Discrepancy of p16 immunohistochemical expression and HPV RNA in penile cancer. A multiplex in situ hybridization/immunohistochemistry approach study." Infectious agents and cancer vol. 16,1 (2021): 23. doi: https://doi.org/10.1186/s13027-021-00363-6
Marino FZ, Sabetta R, Pagliuca F, Brunelli M, Aquino G, Perdonà S, Botti G, Facchini G, Fiorentino F, Di Lauro G, De Sio M, De Vita F, Toni G, Reis RBD, Neder L, Franco R. Correction to: Discrepancy of p16 immunohistochemical expression and HPV RNA in penile cancer. A multiplex in situ hybridization/immunohistochemistry approach study. Infect Agent Cancer. 2021 Apr 12;16(1):23. doi: 10.1186/s13027-021-00363-6. PMID: 33845840; PMCID: PMC8040232.
Copy Download .nbib Format: NLM
[No title available]

Lymphatic research and biology

Michelini S, Ricci M, Amato B, Gentileschi S, Veselenyiova D, Kenanoglu S, Fiorentino A, Kurti D, Baglivo M, Manara E, Basha SH, Priya S, Krajcovic J, Dundar M, Belgrado JP, Dautaj A, Bertelli M.
PMID: 34882481
Lymphat Res Biol. 2021 Dec 08; doi: 10.1089/lrb.2020.0089. Epub 2021 Dec 08.

No abstract available.

Cite
Michelini S, Ricci M, Amato B, et al. . Lymphat Res Biol. 2021;doi: 10.1089/lrb.2020.0089.
Michelini, S., Ricci, M., Amato, B., Gentileschi, S., Veselenyiova, D., Kenanoglu, S., Fiorentino, A., Kurti, D., Baglivo, M., Manara, E., Basha, S. H., Priya, S., Krajcovic, J., Dundar, M., Belgrado, J. P., Dautaj, A., & Bertelli, M. (2021). . Lymphatic research and biology, . https://doi.org/10.1089/lrb.2020.0089
Michelini, Sandro, et al. "." Lymphatic research and biology vol. (2021). doi: https://doi.org/10.1089/lrb.2020.0089
Michelini S, Ricci M, Amato B, Gentileschi S, Veselenyiova D, Kenanoglu S, Fiorentino A, Kurti D, Baglivo M, Manara E, Basha SH, Priya S, Krajcovic J, Dundar M, Belgrado JP, Dautaj A, Bertelli M. . Lymphat Res Biol. 2021 Dec 08; doi: 10.1089/lrb.2020.0089. Epub 2021 Dec 08. PMID: 34882481.
Copy Download .nbib Format: NLM
Victimization among children and adolescents accessing the Meyer pediatric hospital: A retrospective study.

Journal of child and adolescent psychiatric nursing : official publication of the Association of Child and Adolescent Psychiatric Nurses, Inc

Nocentini A, Fiorentini G, Maffei F, Martin R, Losi S, Teodori C, Pisano T, Gori S, De Luca L, Menesini E.
PMID: 34114305
J Child Adolesc Psychiatr Nurs. 2021 Nov;34(4):313-319. doi: 10.1111/jcap.12337. Epub 2021 Jun 10.

PROBLEM: The consistent prevalence and occasionally severe consequences of bullying and victimization suggest the need to include a more accurate assessment of these episodes within the Emergency Departments (ED). However, the literature on mental health related symptoms of bullying/victimization...

Cite
Nocentini A, Fiorentini G, Maffei F, et al. Victimization among children and adolescents accessing the Meyer pediatric hospital: A retrospective study. J Child Adolesc Psychiatr Nurs. 2021;34(4):313-319doi: 10.1111/jcap.12337.
Nocentini, A., Fiorentini, G., Maffei, F., Martin, R., Losi, S., Teodori, C., Pisano, T., Gori, S., De Luca, L., & Menesini, E. (2021). Victimization among children and adolescents accessing the Meyer pediatric hospital: A retrospective study. Journal of child and adolescent psychiatric nursing : official publication of the Association of Child and Adolescent Psychiatric Nurses, Inc, 34(4), 313-319. https://doi.org/10.1111/jcap.12337
Nocentini, Annalaura, et al. "Victimization among children and adolescents accessing the Meyer pediatric hospital: A retrospective study." Journal of child and adolescent psychiatric nursing : official publication of the Association of Child and Adolescent Psychiatric Nurses, Inc vol. 34,4 (2021): 313-319. doi: https://doi.org/10.1111/jcap.12337
Nocentini A, Fiorentini G, Maffei F, Martin R, Losi S, Teodori C, Pisano T, Gori S, De Luca L, Menesini E. Victimization among children and adolescents accessing the Meyer pediatric hospital: A retrospective study. J Child Adolesc Psychiatr Nurs. 2021 Nov;34(4):313-319. doi: 10.1111/jcap.12337. Epub 2021 Jun 10. PMID: 34114305.
Copy Download .nbib Format: NLM
Predicting Risk of Hospital Admission in Patients With Suspected COVID-19 in a Community Setting: Protocol for Development and Validation of a Multivariate Risk Prediction Tool.

JMIR research protocols

Espinosa-Gonzalez AB, Neves AL, Fiorentino F, Prociuk D, Husain L, Ramtale SC, Mi E, Mi E, Macartney J, Anand SN, Sherlock J, Saravanakumar K, Mayer E, de Lusignan S, Greenhalgh T, Delaney BC.
PMID: 33939619
JMIR Res Protoc. 2021 May 25;10(5):e29072. doi: 10.2196/29072.

BACKGROUND: During the pandemic, remote consultations have become the norm for assessing patients with signs and symptoms of COVID-19 to decrease the risk of transmission. This has intensified the clinical uncertainty already experienced by primary care clinicians when assessing...

Cite
Espinosa-Gonzalez AB, Neves AL, Fiorentino F, et al. Predicting Risk of Hospital Admission in Patients With Suspected COVID-19 in a Community Setting: Protocol for Development and Validation of a Multivariate Risk Prediction Tool. JMIR Res Protoc. 2021;10(5):e29072doi: 10.2196/29072.
Espinosa-Gonzalez, A. B., Neves, A. L., Fiorentino, F., Prociuk, D., Husain, L., Ramtale, S. C., Mi, E., Mi, E., Macartney, J., Anand, S. N., Sherlock, J., Saravanakumar, K., Mayer, E., de Lusignan, S., Greenhalgh, T., & Delaney, B. C. (2021). Predicting Risk of Hospital Admission in Patients With Suspected COVID-19 in a Community Setting: Protocol for Development and Validation of a Multivariate Risk Prediction Tool. JMIR research protocols, 10(5), e29072. https://doi.org/10.2196/29072
Espinosa-Gonzalez, Ana Belen, et al. "Predicting Risk of Hospital Admission in Patients With Suspected COVID-19 in a Community Setting: Protocol for Development and Validation of a Multivariate Risk Prediction Tool." JMIR research protocols vol. 10,5 (2021): e29072. doi: https://doi.org/10.2196/29072
Espinosa-Gonzalez AB, Neves AL, Fiorentino F, Prociuk D, Husain L, Ramtale SC, Mi E, Mi E, Macartney J, Anand SN, Sherlock J, Saravanakumar K, Mayer E, de Lusignan S, Greenhalgh T, Delaney BC. Predicting Risk of Hospital Admission in Patients With Suspected COVID-19 in a Community Setting: Protocol for Development and Validation of a Multivariate Risk Prediction Tool. JMIR Res Protoc. 2021 May 25;10(5):e29072. doi: 10.2196/29072. PMID: 33939619; PMCID: PMC8153031.
Copy Download .nbib Format: NLM
Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study.

Therapeutic advances in medical oncology

Ricci C, Capizzi E, Giunchi F, Casolari L, Gelsomino F, Rihawi K, Natali F, Livi V, Trisolini R, Fiorentino M, Ardizzoni A.
PMID: 33299472
Ther Adv Med Oncol. 2020 Nov 30;12:1758835920954802. doi: 10.1177/1758835920954802. eCollection 2020.

INTRODUCTION: Programmed death-ligand 1 (PD-L1) immunohistochemistry (IHC) assessment is mandatory for the single agent pembrolizumab treatment of patients with advanced non-small cell lung cancer (NSCLC). PD-L1 testing has been validated and is currently certified only on formalin-fixed paraffin-embedded materials...

Cite
Ricci C, Capizzi E, Giunchi F, et al. Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study. Ther Adv Med Oncol. 2020;12:1758835920954802doi: 10.1177/1758835920954802.
Ricci, C., Capizzi, E., Giunchi, F., Casolari, L., Gelsomino, F., Rihawi, K., Natali, F., Livi, V., Trisolini, R., Fiorentino, M., & Ardizzoni, A. (2020). Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study. Therapeutic advances in medical oncology, 121758835920954802. https://doi.org/10.1177/1758835920954802
Ricci, Costantino, et al. "Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study." Therapeutic advances in medical oncology vol. 12 (2020): 1758835920954802. doi: https://doi.org/10.1177/1758835920954802
Ricci C, Capizzi E, Giunchi F, Casolari L, Gelsomino F, Rihawi K, Natali F, Livi V, Trisolini R, Fiorentino M, Ardizzoni A. Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study. Ther Adv Med Oncol. 2020 Nov 30;12:1758835920954802. doi: 10.1177/1758835920954802. eCollection 2020. PMID: 33299472; PMCID: PMC7711224.
Copy Download .nbib Format: NLM
HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A/PRAME).

Applied immunohistochemistry & molecular morphology : AIMM

Grillini M, Ricci C, Pino V, Pedrini S, Fiorentino M, Corti B.
PMID: 34508017
Appl Immunohistochem Mol Morphol. 2022 Jan 01;30(1):14-18. doi: 10.1097/PAI.0000000000000972.

PRAME (PReferentially expressed Antigen in MElanoma) is a tumor-associated antigen that was recently found to be expressed by malignant melanocytic lesions but not by benign ones, thus resulting useful in this diagnostic field. PRAME could also be expressed by...

Cite
Grillini M, Ricci C, Pino V, et al. HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A/PRAME). Appl Immunohistochem Mol Morphol. 2022;30(1):14-18doi: 10.1097/PAI.0000000000000972.
Grillini, M., Ricci, C., Pino, V., Pedrini, S., Fiorentino, M., & Corti, B. (2022). HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A/PRAME). Applied immunohistochemistry & molecular morphology : AIMM, 30(1), 14-18. https://doi.org/10.1097/PAI.0000000000000972
Grillini, Marco, et al. "HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A/PRAME)." Applied immunohistochemistry & molecular morphology : AIMM vol. 30,1 (2022): 14-18. doi: https://doi.org/10.1097/PAI.0000000000000972
Grillini M, Ricci C, Pino V, Pedrini S, Fiorentino M, Corti B. HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A/PRAME). Appl Immunohistochem Mol Morphol. 2022 Jan 01;30(1):14-18. doi: 10.1097/PAI.0000000000000972. PMID: 34508017.
Copy Download .nbib Format: NLM
A Hyperthermoactive-Cas9 Editing Tool Reveals the Role of a Unique Arsenite Methyltransferase in the Arsenic Resistance System of Thermus thermophilus HB27.

mBio

Gallo G, Mougiakos I, Bianco M, Carbonaro M, Carpentieri A, Illiano A, Pucci P, Bartolucci S, van der Oost J, Fiorentino G.
PMID: 34872358
mBio. 2021 Dec 07;e0281321. doi: 10.1128/mBio.02813-21. Epub 2021 Dec 07.

Arsenic detoxification systems can be found in a wide range of organisms, from bacteria to humans. In a previous study, we discovered an arsenic-responsive transcriptional regulator in the thermophilic bacterium Thermus thermophilus HB27 (

Cite
Gallo G, Mougiakos I, Bianco M, et al. A Hyperthermoactive-Cas9 Editing Tool Reveals the Role of a Unique Arsenite Methyltransferase in the Arsenic Resistance System of Thermus thermophilus HB27. mBio. 2021;e0281321doi: 10.1128/mBio.02813-21.
Gallo, G., Mougiakos, I., Bianco, M., Carbonaro, M., Carpentieri, A., Illiano, A., Pucci, P., Bartolucci, S., van der Oost, J., & Fiorentino, G. (2021). A Hyperthermoactive-Cas9 Editing Tool Reveals the Role of a Unique Arsenite Methyltransferase in the Arsenic Resistance System of Thermus thermophilus HB27. mBio, e0281321. https://doi.org/10.1128/mBio.02813-21
Gallo, Giovanni, et al. "A Hyperthermoactive-Cas9 Editing Tool Reveals the Role of a Unique Arsenite Methyltransferase in the Arsenic Resistance System of Thermus thermophilus HB27." mBio vol. (2021): e0281321. doi: https://doi.org/10.1128/mBio.02813-21
Gallo G, Mougiakos I, Bianco M, Carbonaro M, Carpentieri A, Illiano A, Pucci P, Bartolucci S, van der Oost J, Fiorentino G. A Hyperthermoactive-Cas9 Editing Tool Reveals the Role of a Unique Arsenite Methyltransferase in the Arsenic Resistance System of Thermus thermophilus HB27. mBio. 2021 Dec 07;e0281321. doi: 10.1128/mBio.02813-21. Epub 2021 Dec 07. PMID: 34872358; PMCID: PMC8649762.
Copy Download .nbib Format: NLM
Common variants at 21q22.3 locus influence .

iScience

Andolfo I, Russo R, Lasorsa VA, Cantalupo S, Rosato BE, Bonfiglio F, Frisso G, Abete P, Cassese GM, Servillo G, Esposito G, Gentile I, Piscopo C, Villani R, Fiorentino G, Cerino P, Buonerba C, Pierri B, Zollo M, Iolascon A, Capasso M.
PMID: 33748697
iScience. 2021 Apr 23;24(4):102322. doi: 10.1016/j.isci.2021.102322. Epub 2021 Mar 17.

The established risk factors of coronavirus disease 2019 (COVID-19) are advanced age, male sex, and comorbidities, but they do not fully explain the wide spectrum of disease manifestations. Genetic factors implicated in the host antiviral response provide for novel...

Cite
Andolfo I, Russo R, Lasorsa VA, et al. Common variants at 21q22.3 locus influence . iScience. 2021;24(4):102322doi: 10.1016/j.isci.2021.102322.
Andolfo, I., Russo, R., Lasorsa, V. A., Cantalupo, S., Rosato, B. E., Bonfiglio, F., Frisso, G., Abete, P., Cassese, G. M., Servillo, G., Esposito, G., Gentile, I., Piscopo, C., Villani, R., Fiorentino, G., Cerino, P., Buonerba, C., Pierri, B., Zollo, M., Iolascon, A., & Capasso, M. (2021). Common variants at 21q22.3 locus influence . iScience, 24(4), 102322. https://doi.org/10.1016/j.isci.2021.102322
Andolfo, Immacolata, et al. "Common variants at 21q22.3 locus influence ." iScience vol. 24,4 (2021): 102322. doi: https://doi.org/10.1016/j.isci.2021.102322
Andolfo I, Russo R, Lasorsa VA, Cantalupo S, Rosato BE, Bonfiglio F, Frisso G, Abete P, Cassese GM, Servillo G, Esposito G, Gentile I, Piscopo C, Villani R, Fiorentino G, Cerino P, Buonerba C, Pierri B, Zollo M, Iolascon A, Capasso M. Common variants at 21q22.3 locus influence . iScience. 2021 Apr 23;24(4):102322. doi: 10.1016/j.isci.2021.102322. Epub 2021 Mar 17. PMID: 33748697; PMCID: PMC7968217.
Copy Download .nbib Format: NLM
Showing 541 to 551 of 551 entries